FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to a composition in the form of particles containing enteric-coated glucosinolates and beta-thioglucosidases. The present invention also represents a method for glucosinolate transformation into isothiocyanate in a small intestine providing oral introduction of an enteric-coated composition of a chemoprotector precursor containing enteric-coated glucosinolates and beta-thioglucosidases into a patient. In the other aspect, the uncoated glucosinolate and beta-tioglucosidase particles may be introduced into an enteric-coated capsule. Preferentially, glucosinolate is glucoraphanin, and beta-thioglucosodase is myrosinase.
EFFECT: enteric coating aims the compound for intestinal release wherein beta-thioglucosodase transforms glucosinolate into isothiocyanate.
29 cl, 5 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING SULFORAPHANE OR SULFORAPHANE PRECURSOR AND EXTRACT OR POWDER OF MILK THISTLE | 2013 |
|
RU2785683C2 |
| COMPOSITIONS COMPRISING A SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MILK THISTLE EXTRACT OR POWDER | 2013 |
|
RU2666953C2 |
| COMPOSITIONS CONTAINING SULFORAPHANE OR PRECURSOR OF SULFORAPHANE AND MUSHROOM EXTRACT OR POWDER | 2013 |
|
RU2680387C2 |
| PRODUCTION OF GLUCOSINOLATES OF AGRICULTURAL BY-PRODUCTS AND WASTES | 2008 |
|
RU2466567C2 |
| METHOD OF OBTAINING PILLS FOR PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2382634C2 |
| VITAMIN COMPOSITION WITH SUSTAINED-RELEASE OF ACTIVE COMPONENT | 2001 |
|
RU2248200C2 |
| CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE COMPOSITIONS AND THEIR USE | 2018 |
|
RU2782016C2 |
| STAVUDINE-CONTAINING SUSTAINED-RELEASE GRANULE | 2001 |
|
RU2239435C2 |
| CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS UNSTABLE IN MEDICINAL ACID MEDIUM | 2006 |
|
RU2440101C2 |
| PANCREATINE MICROPELLET NUCLEI TO BE ENTERO-SOLUBLE COATED | 2006 |
|
RU2408364C2 |
